These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21701001)

  • 1. Role of MRI in minimally invasive focal ablative therapy for prostate cancer.
    Rosenkrantz AB; Scionti SM; Mendrinos S; Taneja SS
    AJR Am J Roentgenol; 2011 Jul; 197(1):W90-6. PubMed ID: 21701001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-tuning robot-assisted radical prostatectomy planning with MRI.
    Finley DS; Margolis D; Raman SS; Ellingson BM; Natarajan S; Tan N; Huang J; Reiter RE
    Urol Oncol; 2013 Aug; 31(6):766-75. PubMed ID: 21906964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy.
    Lindner U; Lawrentschuk N; Weersink RA; Davidson SR; Raz O; Hlasny E; Langer DL; Gertner MR; Van der Kwast T; Haider MA; Trachtenberg J
    Eur Urol; 2010 Jun; 57(6):1111-4. PubMed ID: 20346578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guided e-MRI prostate biopsy can solve the discordance between Gleason score biopsy and radical prostatectomy pathology.
    Labanaris AP; Zugor V; Smiszek R; Nützel R; Kühn R; Engelhard K
    Magn Reson Imaging; 2010 Sep; 28(7):943-6. PubMed ID: 20418041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
    Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
    Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
    Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
    J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
    Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
    Liauw SL; Pitroda SP; Eggener SE; Stadler WM; Pelizzari CA; Vannier MW; Oto A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):378-84. PubMed ID: 22717242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging.
    Lawrentschuk N; Haider MA; Daljeet N; Evans A; Toi A; Finelli A; Trachtenberg J; Zlotta A; Fleshner N
    BJU Int; 2010 May; 105(9):1231-6. PubMed ID: 19817743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer.
    Galgano SJ; Planz VB; Arora S; Rais-Bahrami S
    Curr Urol Rep; 2021 Jan; 22(1):3. PubMed ID: 33403460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Tsivian M; Polascik TJ
    BJU Int; 2011 Aug; 108(3):371. PubMed ID: 21771242
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of maximum slope images generated from dynamic contrast-enhanced MRI to detect locally recurrent prostate carcinoma after prostatectomy: a practical approach.
    Boonsirikamchai P; Kaur H; Kuban DA; Jackson E; Hou P; Choi H
    AJR Am J Roentgenol; 2012 Mar; 198(3):W228-36. PubMed ID: 22358019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.
    Bomers JGR; Cornel EB; Fütterer JJ; Jenniskens SFM; Schaafsma HE; Barentsz JO; Sedelaar JPM; Hulsbergen-van de Kaa CA; Witjes JA
    World J Urol; 2017 May; 35(5):703-711. PubMed ID: 27541586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis.
    Le Nobin J; Rosenkrantz AB; Villers A; Orczyk C; Deng FM; Melamed J; Mikheev A; Rusinek H; Taneja SS
    J Urol; 2015 Aug; 194(2):364-70. PubMed ID: 25711199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls with MRI evaluation of prostate cancer detection: comparison of findings with histopathological assessment of retropubic radical prostatectomy specimens.
    Okamura T; Umemoto Y; Yamashita K; Suzuki S; Shirai T; Hashimoto Y; Kohri K
    Urol Int; 2006; 77(4):301-6. PubMed ID: 17135778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
    Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
    Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can conventional magnetic resonance imaging, prostate needle biopsy, or their combination predict the laterality of clinically localized prostate cancer?
    Jeong CW; Ku JH; Moon KC; Hong SK; Byun SS; Cho JY; Kim HH; Kim SH; Lee SE; Kwak C
    Urology; 2012 Jun; 79(6):1322-7. PubMed ID: 22656409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.
    Mouraviev V; Mayes JM; Sun L; Madden JF; Moul JW; Polascik TJ
    Cancer; 2007 Aug; 110(4):906-10. PubMed ID: 17587207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy.
    Low RN; Fuller DB; Muradyan N
    AJR Am J Roentgenol; 2011 Oct; 197(4):907-15. PubMed ID: 21940578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.